Viatris (VTRS) Work In Process (2019 - 2026)
Viatris' (VTRS) quarterly Work In Process came in at $424.8 million in Q1 2026, down 13.96% year-on-year from $493.7 million in Q1 2025, and down 13.61% quarter-over-quarter from $491.7 million in Q4 2025.
Viatris (VTRS) Work In Process (2019 - 2026) Analysis & Trends
Viatris' Work In Process history runs 8 years deep, the most recent figure standing at $424.8 million for Q1 2026.
- On a quarterly basis, Work In Process fell 13.96% year-over-year to $424.8 million in Q1 2026; TTM through Mar 2026 was $424.8 million, a 13.96% decrease from a year earlier, with the FY2025 full-year figure at $491.7 million, down 6.75% from the prior year.
- Work In Process declined to $424.8 million in Q1 2026 per VTRS's latest filing, from $491.7 million in the prior quarter.
- Across five years, Work In Process topped out at $1.1 billion in Q2 2023 and bottomed at $424.8 million in Q1 2026.
- The 5-year median for Work In Process is $602.1 million (2023), against an average of $696.8 million.
- Across the five-year window, Work In Process surged 57.37% in 2024 and plunged 55.02% in 2025, its largest moves.
- Year by year, Work In Process stood at $755.4 million in 2022, then fell by 20.29% to $602.1 million in 2023, then slipped by 12.42% to $527.3 million in 2024, then fell by 6.75% to $491.7 million in 2025, then dropped by 13.61% to $424.8 million in 2026.
- Per Business Quant, the three latest VTRS Work In Process figures stand at $424.8 million (Q1 2026), $491.7 million (Q4 2025), and $516.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 424.80 Mn |
| Dec 31, 2025 | 491.70 Mn |
| Sep 30, 2025 | 516.00 Mn |
| Jun 30, 2025 | 531.70 Mn |
| Mar 31, 2025 | 493.70 Mn |
| Dec 31, 2024 | 527.30 Mn |
| Sep 30, 2024 | 554.80 Mn |
| Jun 30, 2024 | 576.50 Mn |
| Mar 31, 2024 | 1.10 Bn |
| Dec 31, 2023 | 602.10 Mn |
| Sep 30, 2023 | 1.03 Bn |
| Jun 30, 2023 | 1.13 Bn |
| Mar 31, 2023 | 697.40 Mn |
| Dec 31, 2022 | 755.40 Mn |
| Sep 30, 2022 | 824.60 Mn |
| Jun 30, 2022 | 821.70 Mn |
| Mar 31, 2022 | 767.50 Mn |
| Dec 31, 2021 | 993.30 Mn |
| Sep 30, 2021 | 836.40 Mn |
| Jun 30, 2021 | 1.15 Bn |